Clinical features of Hermansky–Pudlak syndrome (HPS) pulmonary fibrosis and idiopathic pulmonary fibrosis (IPF)
HPS-1 or HPS-4 pulmonary fibrosis | HPS-2 pulmonary fibrosis | IPF | |
Onset of pulmonary symptoms | Middle age | Children or young adults | >50 years of age |
Acute exacerbations | Yes | Unknown | Yes |
Oculocutaneous albinism | Yes | Yes | No |
Nystagmus | Yes | Yes | No |
Excessive bleeding | Yes | Yes | No |
HRCT scan finding of ground-glass opacification | Yes | Yes | No |
Type II epithelial cell enlargement | Yes | Yes | No |
Giant lamellar bodies | Yes | Yes | No |
Foamy alveolar macrophages | Yes | Unknown | No |
Ceroid lipofuscin tissue deposition | Yes | Yes | No |
Pulmonary histopathology | UIP, NSIP, DAD | UIP, NSIP, DIP | UIP |
HRCT: high-resolution computed tomography; UIP: usual interstitial pneumonia; NSIP: nonspecific interstitial pneumonia; DAD: diffuse alveolar damage; DIP: desquamative interstitial pneumonitis.